Source comparison
MOTS-C for CrossFit Athletes: Performance Comparison
MOTS-C AMPK activation, mitochondrial biogenesis Moderate to high (extends threshold work capacity by 15–25%) High (insulin-independent glucose uptake during exercise) None High-volume WODs, AMRAP sets, competition prep with compressed recovery windows Creatin
This comparison does not assign a generated winner or score.
- MOTS-C
- AMPK activation, mitochondrial biogenesis
- Moderate to high (extends threshold work capacity by 15–25%)
- High (insulin-independent glucose uptake during exercise)
- None
- High-volume WODs, AMRAP sets, competition prep with compressed recovery windows
- Creatine Monohydrate
- Phosphocreatine replenishment
- Low (effective only in <10-second efforts)
- Maximal strength lifts, short sprints, explosive power
- Beta-Alanine
- Intracellular pH buffering via carnosine synthesis
- Moderate (delays acidosis in 1–4 minute efforts)
- Repeated high-intensity intervals, Fran-style benchmark WODs
- BPC-157
- Angiogenesis, collagen synthesis, nitric oxide modulation
- High (accelerates tendon and ligament healing)
- Injury recovery, high-frequency Olympic lifting blocks
- GLP-1 Agonists (Semaglutide)
- Appetite suppression, gastric emptying delay
- None (may reduce work capacity if under-fuelled)
- Body recomposition, weight cuts, appetite control during caloric deficits
- Bottom Line
- MOTS-C is the only compound in this comparison that directly improves substrate efficiency during sustained efforts. The metabolic bottleneck in CrossFit. Creatine and beta-alanine address specific energy systems but don't extend aerobic-glycolytic threshold. BPC-157 handles tissue repair but offers zero performance benefit. GLP-1 agonists support body composition but can impair training if macros aren't dialled. For athletes running 5–6 training days weekly with mixed-modal programming, MOTS-C pairs with creatine and beta-alanine to cover all energy system demands.